These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22040230)

  • 1. Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology.
    Florholmen J; Fries W
    Scand J Gastroenterol; 2011 Dec; 46(12):1407-17. PubMed ID: 22040230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease.
    Vitali R; Stronati L; Negroni A; Di Nardo G; Pierdomenico M; del Giudice E; Rossi P; Cucchiara S
    Am J Gastroenterol; 2011 Nov; 106(11):2029-40. PubMed ID: 21788990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.
    Florholmen J
    Scand J Gastroenterol; 2015 Jan; 50(1):43-52. PubMed ID: 25523555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.
    Han NY; Kim EH; Choi J; Lee H; Hahm KB
    J Dig Dis; 2012 Oct; 13(10):497-503. PubMed ID: 22988922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease.
    Miyoshi E; Shinzaki S; Fujii H; Iijima H; Kamada Y; Takehara T
    Proteomics Clin Appl; 2016 Apr; 10(4):384-90. PubMed ID: 26427763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic insights on the metabolism in inflammatory bowel disease.
    Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
    World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
    Dijkstra G; Moshage H; van Dullemen HM; de Jager-Krikken A; Tiebosch AT; Kleibeuker JH; Jansen PL; van Goor H
    J Pathol; 1998 Dec; 186(4):416-21. PubMed ID: 10209492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.